FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 0 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 1 |
| Most recent action | March 5, 2026 |
Enforcement history
On 2026-03-05, Argus HQ recorded an FDA Form 483 inspection citation for Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil, rated "high" severity in Argus HQ's classification: Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil -- FDA 483: 1 observation (2026-03-05). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- What is the most recent FDA action against Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil?
- The most recent FDA event Argus HQ has on file for Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil is dated 2026-03-05, with a severity rating of "high" in Argus HQ's classification. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
- Does Argus HQ track new FDA actions for Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil automatically?
- Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil is observed, this page's event count and history update automatically.
- How many FDA actions does Argus HQ track for Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil?
- 1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.
- What is the most recent FDA action on file for Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil?
- March 5, 2026. Argus HQ ingests new FDA enforcement records daily.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil vs Philips North America
- Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil vs Medline Industries, LP
- Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil vs Boston Scientific Corporation
- Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil vs Baxter Healthcare Corporation
- Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Mar 5, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil — FDA Enforcement History. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/delta-kozmetik-sanayi-ve-ticaret-selim-yesil
"Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil — FDA Enforcement History." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/delta-kozmetik-sanayi-ve-ticaret-selim-yesil.
Argus HQ Research. "Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil — FDA Enforcement History." Digital Empire Holdings LLC. Accessed August 17, 2026. https://argushq.ai/company/delta-kozmetik-sanayi-ve-ticaret-selim-yesil.
@misc{argushq_argushq_ai_company_delta_kozmetik_sanayi_ve_ticaret_selim_yesil_2026,
title = {Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil — FDA Enforcement History},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/delta-kozmetik-sanayi-ve-ticaret-selim-yesil},
note = {Accessed: August 17, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗

